Nonetheless, the combined targeting of NF-κB and STAT3 offers a promising approach for the management of liver cancer such as HCC, necessitating further compelling experiments to confirm the robustness of vinpocetine’s effects. Here, NFKB1 is linked to hepatocellular carcinoma.